Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Directorate Change

28 Jan 2016 07:00

RNS Number : 2335N
Scapa Group PLC
28 January 2016
 

28 January 2016

Scapa Group plc

('Scapa' or 'the Company')

 

Directorate Change and Director Dealing

 

Scapa, a global manufacturer of bonding materials and solutions, announces that Paul Edwards has notified the Board of his intention to retire from his role as Group Finance Director on 30 April 2016. Paul Edwards has served as Group Finance Director since September 2010. He will remain with the Company in an advisory capacity until 31 October 2016.

Following a thorough and wide reaching search, the Board is delighted also to announce the appointment of Graham Hardcastle as Group Finance Director, to take effect when Paul Edwards steps down from the Board on 30 April 2016. Graham Hardcastle joins the Board with effect from 1 February 2016. He was previously Group Finance Director at Bridon International and prior to that he held a number of senior finance positions at Smith & Nephew plc and Smiths Group plc.

James Wallace, Chairman of the Board, commented: "The Board thanks Paul for his contribution to the success of the Company during his tenure. He helped lead the Company during a period of exceptional development and the Board wishes him well for the future. Graham brings to the role very strong business skills and experience in healthcare and global markets, which will be of great benefit to the Group as it pursues its strategy for growth."

The Company makes the following disclosures in relation to Graham Hardcastle's appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:

1. Director's full name: Graham Stuart Hardcastle

 

Director's age: 51 years

2. Other directorships / partnerships held during the last five years:

Name of Company / Partnership:

 

Bridon Scheme Trustees Limited

 

Bridon (Hanghou) Ropes Co Ltd

 

Bridon Scanrope AS

 

Bridon TopCo (Jersey) Ltd

 

Bridon Singapore (PTE) Limited

 

Bridon Hangzhou Limited (China)

 

Bridon South East Asia Limited

 

Bridon Hong Kong Limited

 

PT Bridon

 

Smith and Nephew Orthopedics Beijing Limited

 

Mr. Hardcastle is no longer a director of any of the aforementioned companies.

3. Other information: there is no other information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

Director Dealing

The Company also announces that the Remuneration Committee has approved the grant of awards to the Executive Directors and other Senior Executives under the Scapa Group plc 2015 Value Creation Plan, effective 1 February 2016. Details of the Value Creation Plan are set out in the Circular posted to Shareholders on 29 October 2015. The awards are in the form of nil cost options and those granted to the Executive Directors are disclosed in the table below:

Name

Job title

Award - Proportion of Value Creation Plan

Heejae Chae

Chief Executive

40%

Graham Hardcastle

Group Finance Director

20%

 

 

Enquiries:

Rebecca Smith, Company Secretary Tel: 0161 301 7430

Scapa Group plc

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASELESWFMSEIF
Date   Source Headline
1st Dec 201510:11 amRNSHolding(s) in Company
1st Dec 201510:10 amRNSHolding(s) in Company
30th Nov 201510:34 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSInterim Results
3rd Nov 20154:55 pmRNSHolding(s) in Company
3rd Nov 20154:54 pmRNSShareholder Circular Posted
13th Oct 20157:00 amRNSTrading Statement
10th Sep 20151:03 pmRNSAdditional Listing
9th Sep 20159:48 amRNSHolding(s) in Company
1st Sep 20153:57 pmRNSBlocklisting Interim Review
1st Sep 20153:29 pmRNSAdditional Listing
11th Aug 20151:28 pmRNSAdditional Listing
10th Aug 20159:46 amRNSDirector/PDMR Shareholding
23rd Jul 20159:21 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSAGM Statement
14th Jul 20153:56 pmRNSAdditional Listing
13th Jul 20151:26 pmRNSHolding(s) in Company
2nd Jul 201511:15 amRNSAdditional Listing
17th Jun 20157:00 amRNSHealthcare Site Visit
16th Jun 20159:15 amRNSAdditional Listing
10th Jun 20152:54 pmRNSHolding(s) in Company
5th Jun 20159:01 amRNSHolding(s) in Company
4th Jun 20159:31 amRNSHolding(s) in Company
3rd Jun 20158:59 amRNSHolding(s) in Company
27th May 20157:00 amRNSFinal Results
28th Apr 20153:27 pmRNSAdditional Listing
9th Apr 20157:00 amRNSTrading Statement
7th Apr 20154:38 pmRNSHolding(s) in Company
7th Apr 20153:43 pmRNSAdditional Listing
31st Mar 20159:12 amRNSTotal Voting Rights
30th Mar 20154:02 pmRNSAdditional Listing
30th Mar 20152:58 pmRNSDirector/PDMR Shareholding
18th Mar 20154:45 pmRNSHolding(s) in Company
16th Mar 20154:20 pmRNSAdditional Listing
10th Mar 20154:10 pmRNSAdditional Listing
9th Mar 20157:00 amRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSDirector/PDMR Shareholding
2nd Mar 20153:58 pmRNSAdditional Listing
2nd Mar 20157:00 amRNSAcquisition
23rd Feb 20159:08 amRNSHolding(s) in Company
16th Feb 20159:01 amRNSHolding(s) in Company
13th Feb 20159:09 amRNSHolding(s) in Company
11th Feb 201510:52 amRNSHolding(s) in Company
9th Feb 20151:35 pmRNSHolding(s) in Company
9th Feb 201510:33 amRNSBlocklisting Interim Review
4th Feb 201512:18 pmRNSHolding(s) in Company
23rd Jan 20159:59 amRNSHolding(s) in Company
31st Dec 201412:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.